Blood-Thinning Medication Associated With Serious – Even Fatal – Health Complications

DALLAS (August 6, 2015) – The blood-thinning medication Xarelto, distributed in the U.S. by Janssen Pharmaceuticals, has been linked to several severe complications, including hemorrhagic strokes, excessive internal bleeding and death. The national law firm of Baron & Budd is investigating potential lawsuits on behalf of patients who have suffered adverse reactions to the drug.

The U.S. Food and Drug Administration approved Xarelto for use in 2011 to prevent blood clots from developing and to treat existing blood clots in patients. However, the drug has been associated with several complications, including bleeding in the brain and stomach as well as other cases of uncontrolled internal bleeding. In an article that appeared in the June 15 issue of JAMA Ophthalmology, doctors reported several elderly patients suffered bleeding between the retina and lens of the eye after moving to Xarelto from another blood-thinning medication, Warfarin.

Xarelto has been marketed by Janssen (a subsidiary of Johnson & Johnson) as a superior anti-coagulant to Warfarin, which is marketed under the brand name of Coumadin. Warfarin has been prescribed since the 1950s, but users of the medication need to be regularly monitored by a physician. Xarelto is marketed as more convenient than warfarin because patients purportedly do not need to be monitored nearly as often. While warfarin can cause similar bleeding events, those complications can typically be reversed through the immediate administration of high doses of Vitamin K or frozen plasma. Those options are not effective in treating bleeding events associated with Xarelto, and there is no other known antidote.

“There have been far too many instances of patients taking this drug and suffering devastating side effects,” said Russell Budd, president and managing shareholder of the national law firm of Baron & Budd. “Pharmaceutical companies owe it to patients to introduce the safest possible products to the marketplace, and must be held accountable when they are found to be negligent in this obligation.”

Call the national law firm of Baron & Budd at 866-520-2755 if you or a loved one has suffered adverse effects from taking Xarelto, or send an email to info@baronbudd.com. One of our attorneys will let you know if you qualify to file a lawsuit against the manufacturer.

About Baron & Budd, P.C.

The law firm of Baron & Budd, P.C., with offices in Dallas, Baton Rouge, Austin and Los Angeles, is a nationally recognized law firm with a nearly 40-year history of "Protecting What’s Right" for people, communities and businesses harmed by negligence. Baron & Budd’s size and resources enable the firm to take on large and complex cases. The firm represents individuals and government and business entities in areas as diverse as dangerous pharmaceuticals and medical devices, environmental contamination, the Gulf oil spill, financial fraud, overtime violations, deceptive advertising, automotive defects, trucking accidents, nursing home abuse, and asbestos-related illnesses such as mesothelioma.